Gentium S.p.A. announced today that, the Company has filed the documentation requesting a Re-examination of the negative opinion given by the European Medicines Agency's Committee for Medicinal Products for Human Use , regarding the Marketing Authorisation for Defibrotide to treat and prevent hepatic veno-occlusive disease in adults and children ... (more)
http://www.benzinga.com/news/13/06/3644822/gentium-requests-re-examination-of-negative-opinion-of-defibrotide-maa-by-ema
http://www.benzinga.com/news/13/06/3644822/gentium-requests-re-examination-of-negative-opinion-of-defibrotide-maa-by-ema
No comments:
Post a Comment